Modification  ||| S:0 E:13 ||| NNP
and  ||| S:13 E:17 ||| CC
implementation  ||| S:17 E:32 ||| NN
of  ||| S:32 E:35 ||| IN
NCCN  ||| S:35 E:40 ||| NNP
guidelines  ||| S:40 E:51 ||| NNS
on  ||| S:51 E:54 ||| IN
breast  ||| S:54 E:61 ||| JJ
cancer  ||| S:61 E:68 ||| NN
in  ||| S:68 E:71 ||| IN
the  ||| S:71 E:75 ||| DT
Middle  ||| S:75 E:82 ||| NNP
East  ||| S:82 E:87 ||| NNP
and  ||| S:87 E:91 ||| CC
North  ||| S:91 E:97 ||| NNP
Africa  ||| S:97 E:104 ||| NNP
region  ||| S:104 E:111 ||| NN
Published  ||| S:111 E:121 ||| VBN
data  ||| S:121 E:126 ||| NNS
from  ||| S:126 E:131 ||| IN
the  ||| S:131 E:135 ||| DT
Middle  ||| S:135 E:142 ||| NNP
East  ||| S:142 E:147 ||| NNP
and  ||| S:147 E:151 ||| CC
North  ||| S:151 E:157 ||| NNP
Africa  ||| S:157 E:164 ||| NNP
( ||| S:164 E:165 ||| -LRB-
MENA ||| S:165 E:169 ||| NNP
)  ||| S:169 E:171 ||| -RRB-
region  ||| S:171 E:178 ||| NN
indicate  ||| S:178 E:187 ||| VBP
suboptimal  ||| S:187 E:198 ||| JJ
quality  ||| S:198 E:206 ||| NN
of  ||| S:206 E:209 ||| IN
cancer  ||| S:209 E:216 ||| NN
care ||| S:216 E:220 ||| NN
,  ||| S:220 E:222 ||| ,
while  ||| S:222 E:228 ||| IN
the  ||| S:228 E:232 ||| DT
World  ||| S:232 E:238 ||| NNP
Health  ||| S:238 E:245 ||| NNP
Organization  ||| S:245 E:258 ||| NNP
predicts  ||| S:258 E:267 ||| VBZ
an  ||| S:267 E:270 ||| DT
increase  ||| S:270 E:279 ||| NN
in  ||| S:279 E:282 ||| IN
cancer  ||| S:282 E:289 ||| NN
cases  ||| S:289 E:295 ||| NNS
in  ||| S:295 E:298 ||| IN
developing  ||| S:298 E:309 ||| VBG
countries ||| S:309 E:318 ||| NNS
.  ||| S:318 E:320 ||| .
Major  ||| S:320 E:326 ||| JJ
advances  ||| S:326 E:335 ||| NNS
in  ||| S:335 E:338 ||| IN
breast  ||| S:338 E:345 ||| JJ
cancer  ||| S:345 E:352 ||| NN
management  ||| S:352 E:363 ||| NN
mandate  ||| S:363 E:371 ||| VBD
the  ||| S:371 E:375 ||| DT
development  ||| S:375 E:387 ||| NN
of  ||| S:387 E:390 ||| IN
guidelines  ||| S:390 E:401 ||| NNS
to  ||| S:401 E:404 ||| TO
improve  ||| S:404 E:412 ||| VB
the  ||| S:412 E:416 ||| DT
quality  ||| S:416 E:424 ||| NN
and  ||| S:424 E:428 ||| CC
efficacy  ||| S:428 E:437 ||| NN
of  ||| S:437 E:440 ||| IN
oncology  ||| S:440 E:449 ||| JJ
practice  ||| S:449 E:458 ||| NN
in  ||| S:458 E:461 ||| IN
the  ||| S:461 E:465 ||| DT
MENA  ||| S:465 E:470 ||| NNP
region ||| S:470 E:476 ||| NN
.  ||| S:476 E:478 ||| .
A  ||| S:478 E:480 ||| DT
Breast  ||| S:480 E:487 ||| NNP
Cancer  ||| S:487 E:494 ||| NNP
Regional  ||| S:494 E:503 ||| NNP
Guidelines  ||| S:503 E:514 ||| NNP
Committee  ||| S:514 E:524 ||| NNP
was  ||| S:524 E:528 ||| VBD
organized  ||| S:528 E:538 ||| VBN
and  ||| S:538 E:542 ||| CC
activated ||| S:542 E:551 ||| NN
,  ||| S:551 E:553 ||| ,
comprising  ||| S:553 E:564 ||| VBG
experts  ||| S:564 E:572 ||| NNS
from  ||| S:572 E:577 ||| IN
various  ||| S:577 E:585 ||| JJ
regional  ||| S:585 E:594 ||| JJ
cancer  ||| S:594 E:601 ||| NN
institutions ||| S:601 E:613 ||| NNS
.  ||| S:613 E:615 ||| .
The  ||| S:615 E:619 ||| DT
multidisciplinary  ||| S:619 E:637 ||| JJ
team  ||| S:637 E:642 ||| NN
included  ||| S:642 E:651 ||| VBD
12  ||| S:651 E:654 ||| CD
medical  ||| S:654 E:662 ||| JJ
oncologists ||| S:662 E:673 ||| NN
,  ||| S:673 E:675 ||| ,
3  ||| S:675 E:677 ||| CD
radiation  ||| S:677 E:687 ||| NN
oncologists ||| S:687 E:698 ||| NN
,  ||| S:698 E:700 ||| ,
2  ||| S:700 E:702 ||| CD
radiologists ||| S:702 E:714 ||| NN
,  ||| S:714 E:716 ||| ,
2  ||| S:716 E:718 ||| CD
surgeons ||| S:718 E:726 ||| NN
,  ||| S:726 E:728 ||| ,
and  ||| S:728 E:732 ||| CC
1  ||| S:732 E:734 ||| CD
pathologist ||| S:734 E:745 ||| NNS
.  ||| S:745 E:747 ||| .
The  ||| S:747 E:751 ||| DT
committee  ||| S:751 E:761 ||| NN
members  ||| S:761 E:769 ||| NNS
agreed  ||| S:769 E:776 ||| VBD
on  ||| S:776 E:779 ||| IN
adapting  ||| S:779 E:788 ||| VBG
the  ||| S:788 E:792 ||| DT
current  ||| S:792 E:800 ||| JJ
NCCN  ||| S:800 E:805 ||| NNP
Clinical  ||| S:805 E:814 ||| NNP
Practice  ||| S:814 E:823 ||| NNP
Guidelines  ||| S:823 E:834 ||| NNP
in  ||| S:834 E:837 ||| IN
Oncology  ||| S:837 E:846 ||| NNP
( ||| S:846 E:847 ||| -LRB-
NCCN  ||| S:847 E:852 ||| NNP
Guidelines ||| S:852 E:862 ||| NNP
)  ||| S:862 E:864 ||| -RRB-
on  ||| S:864 E:867 ||| IN
Breast  ||| S:867 E:874 ||| NNP
Cancer  ||| S:874 E:881 ||| NNP
for  ||| S:881 E:885 ||| IN
use  ||| S:885 E:889 ||| NN
in  ||| S:889 E:892 ||| IN
the  ||| S:892 E:896 ||| DT
MENA  ||| S:896 E:901 ||| NNP
region  ||| S:901 E:908 ||| NN
to  ||| S:908 E:911 ||| TO
achieve  ||| S:911 E:919 ||| VB
common  ||| S:919 E:926 ||| JJ
practice  ||| S:926 E:935 ||| NN
standards  ||| S:935 E:945 ||| NNS
for  ||| S:945 E:949 ||| IN
treating  ||| S:949 E:958 ||| VBG
patients ||| S:958 E:966 ||| NNS
.  ||| S:966 E:968 ||| .
The  ||| S:968 E:972 ||| DT
members  ||| S:972 E:980 ||| NNS
suggested  ||| S:980 E:990 ||| VBD
several  ||| S:990 E:998 ||| JJ
modifications  ||| S:998 E:1012 ||| NNS
to  ||| S:1012 E:1015 ||| TO
the  ||| S:1015 E:1019 ||| DT
guidelines ||| S:1019 E:1029 ||| NNS
,  ||| S:1029 E:1031 ||| ,
especially  ||| S:1031 E:1042 ||| RB
those  ||| S:1042 E:1048 ||| DT
related  ||| S:1048 E:1056 ||| VBN
to  ||| S:1056 E:1059 ||| TO
risk  ||| S:1059 E:1064 ||| VB
factor  ||| S:1064 E:1071 ||| NN
profiles ||| S:1071 E:1079 ||| NNS
.  ||| S:1079 E:1081 ||| .
United  ||| S:1081 E:1088 ||| NNP
States-based  ||| S:1088 E:1101 ||| NNP
NCCN  ||| S:1101 E:1106 ||| NNP
experts  ||| S:1106 E:1114 ||| NNS
reviewed  ||| S:1114 E:1123 ||| VBN
these  ||| S:1123 E:1129 ||| DT
recommendations  ||| S:1129 E:1145 ||| NNS
before  ||| S:1145 E:1152 ||| IN
final  ||| S:1152 E:1158 ||| JJ
approval ||| S:1158 E:1166 ||| NN
.  ||| S:1166 E:1168 ||| .
The  ||| S:1168 E:1172 ||| DT
MENA-NCCN  ||| S:1172 E:1182 ||| JJ
Breast  ||| S:1182 E:1189 ||| NNP
Cancer  ||| S:1189 E:1196 ||| NNP
Guidelines  ||| S:1196 E:1207 ||| NNP
modification  ||| S:1207 E:1220 ||| NN
process  ||| S:1220 E:1228 ||| NN
was  ||| S:1228 E:1232 ||| VBD
the  ||| S:1232 E:1236 ||| DT
first  ||| S:1236 E:1242 ||| JJ
initiative  ||| S:1242 E:1253 ||| NN
in  ||| S:1253 E:1256 ||| IN
the  ||| S:1256 E:1260 ||| DT
development  ||| S:1260 E:1272 ||| NN
of  ||| S:1272 E:1275 ||| IN
common  ||| S:1275 E:1282 ||| JJ
practice  ||| S:1282 E:1291 ||| NN
guidelines  ||| S:1291 E:1302 ||| NNS
in  ||| S:1302 E:1305 ||| IN
the  ||| S:1305 E:1309 ||| DT
region ||| S:1309 E:1315 ||| NN
.  ||| S:1315 E:1317 ||| .
This  ||| S:1317 E:1322 ||| DT
project  ||| S:1322 E:1330 ||| NN
may  ||| S:1330 E:1334 ||| MD
serve  ||| S:1334 E:1340 ||| VB
as  ||| S:1340 E:1343 ||| IN
a  ||| S:1343 E:1345 ||| DT
foundation  ||| S:1345 E:1356 ||| NN
for  ||| S:1356 E:1360 ||| IN
the  ||| S:1360 E:1364 ||| DT
development  ||| S:1364 E:1376 ||| NN
of  ||| S:1376 E:1379 ||| IN
evidence-based  ||| S:1379 E:1394 ||| JJ
practice  ||| S:1394 E:1403 ||| NN
standards ||| S:1403 E:1412 ||| NNS
,  ||| S:1412 E:1414 ||| ,
and  ||| S:1414 E:1418 ||| CC
improve  ||| S:1418 E:1426 ||| VB
collaborative  ||| S:1426 E:1440 ||| JJ
projects  ||| S:1440 E:1449 ||| NNS
and  ||| S:1449 E:1453 ||| CC
initiatives ||| S:1453 E:1464 ||| NNS
.  ||| S:1464 E:1466 ||| .
